Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall J Bateman

Showing results (101-110 of 391) with videos related to

Pageof 40
Sort By:
EMBO Molecular Medicine|May 5, 2021
Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tauNiklas Mattsson-Carlgren, Shorena Janelidze, Randall J Bateman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentTammie L S Benzinger, Arnaud Charil, Brian A Gordon, et al.
Geroscience|April 21, 2022
Investigating the combination of plasma amyloid-beta and geroscience biomarkers on the incidence of clinically meaningful cognitive decline in older adultsWan-Hsuan Lu, Kelly Virecoulon Giudici, John E Morley, et al.
Neurobiology of Aging|December 12, 2018
Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer NetworkAurélie Bussy, B Joy Snider, Dean Coble, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2020
Item response theory analysis of the Clinical Dementia RatingYan Li, Chengjie Xiong, Andrew J Aschenbrenner, et al.
Alzheimer'S Research & Therapy|March 8, 2016
A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humansMikko Hölttä, Robert A Dean, Eric Siemers, et al.
Annals of Clinical and Translational Neurology|August 3, 2021
MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathologyChihiro Sato, Nipun Mallipeddi, Nupur Ghoshal, et al.
Annals of Neurology|March 10, 2023
Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNSBrendan P Lucey, Haiyan Liu, Cristina D Toedebusch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 30, 2024
A genetic and proteomic comparison of key AD biomarkers across tissuesThomas W Marsh, Daniel Western, Jigyasha Timsina, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2019
Persistent metabolic youth in the aging female brainManu S Goyal, Tyler M Blazey, Yi Su, et al.
Pageof 40

Showing results (101-110 of 391) with videos related to

Sort By:
Pageof 40
EMBO Molecular Medicine|May 5, 2021
Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tauNiklas Mattsson-Carlgren, Shorena Janelidze, Randall J Bateman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentTammie L S Benzinger, Arnaud Charil, Brian A Gordon, et al.
Geroscience|April 21, 2022
Investigating the combination of plasma amyloid-beta and geroscience biomarkers on the incidence of clinically meaningful cognitive decline in older adultsWan-Hsuan Lu, Kelly Virecoulon Giudici, John E Morley, et al.
Neurobiology of Aging|December 12, 2018
Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer NetworkAurélie Bussy, B Joy Snider, Dean Coble, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2020
Item response theory analysis of the Clinical Dementia RatingYan Li, Chengjie Xiong, Andrew J Aschenbrenner, et al.
Alzheimer'S Research & Therapy|March 8, 2016
A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humansMikko Hölttä, Robert A Dean, Eric Siemers, et al.
Annals of Clinical and Translational Neurology|August 3, 2021
MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathologyChihiro Sato, Nipun Mallipeddi, Nupur Ghoshal, et al.
Annals of Neurology|March 10, 2023
Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNSBrendan P Lucey, Haiyan Liu, Cristina D Toedebusch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 30, 2024
A genetic and proteomic comparison of key AD biomarkers across tissuesThomas W Marsh, Daniel Western, Jigyasha Timsina, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2019
Persistent metabolic youth in the aging female brainManu S Goyal, Tyler M Blazey, Yi Su, et al.
Pageof 40